TNGX R&D Expense Growth
Tango Therapeutics Inc · R&D Expense Growth
TNGX R&D Expense Growth
Latest reported-8.17%period ending
TNGX FY R&D Growth (YoY) (0.00% → -8.17%)
Latest values, visible window
High-resolution chart · PNG
TNGX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -8.1665% | |
| 24.931% | |
| 8.7738% | |
| 36.4135% | |
| 55.3% | |
| 54.8956% | |
| 0% |